An edition of Marketing of Clozaril (1991)
Marketing of Clozaril
improved safety or barrier to access : hearing before the Subcommittee on Antitrust, Monopolies and Business Rights of the Committee on the Judiciary, United States Senate, One Hundred Second Congress, first session, on the marketing of Clozaril, a drug for the treatment of schizophrenia, March 5, 1991.
By United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Antitrust, Monopolies, and Business Rights.
0 (0 Ratings)
0 Want to read0 Currently reading0 Have read
0 Want to read0 Currently reading0 Have read
Publish Date
1991
Publisher
U.S. G.P.O.,For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office
Language
eng
Pages
139
Description: